The elucidation of the mechanisms underlying contrast media induced nephrotoxicity and its prophylaxis.

阐明造影剂诱发肾毒性的机制及其预防。

基本信息

  • 批准号:
    17590471
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2005
  • 资助国家:
    日本
  • 起止时间:
    2005 至 2006
  • 项目状态:
    已结题

项目摘要

Radiographic contrast medium (RCM) is one of major causes of drug-induced acute renal failure, although the cellular mechanisms are not fully understood. We investigated that RCM induces apoptosis in renal tubular cells, in which decrease in bcl-2 mRNA and subsequent activation of caspase-9 and caspase-3 are involved. Moreover, RCM-induced reduction in Bcl-2 expression was found to be mediated by decrease in phosphorylated Akt (pAkt) and cyclic AMP (cAMP)-responsive element binding protein (CREB) phosphorilation. Various RCM increased ceramide content in renal tubular cells, in which the increase was closely related to the loss of cell viability. Both the elevation of ceramide content and cell injury induced by RCM were reversed by fumonisin Bl but not D609, suggesting a role for de novo ceramide synthesis. Like RCM, ceramide decreased pAkt, reduced Bcl-2 expression, enhanced caspase-9 and caspase-3 activities, and led to apoptosis. The protective effect of fumonisin Bl was also observed in vivo in murine model of RCM nephropathy. Moreover, a prostacyclin analog beraprost induce the elevation of endogenous cAMP effectively prevents radiocontrast nephropathy, in which activation of A kinase/PI 3-kinase/Akt followed by CREB phosphorylation are involved.These findings suggest that ceramide synthesis inhibitor or beraprost may be potentially useful for the prophylaxis of radiographic contrast media nephrotoxicity.
放射性造影剂(RCM)是引起药物性急性肾功能衰竭的主要原因之一,但其细胞机制尚不完全清楚。我们研究了RCM诱导肾小管细胞凋亡,其中涉及bcl-2 mRNA的降低和随后的caspase-9和caspase-3的激活。此外,发现RCM诱导的Bcl-2表达减少是通过磷酸化Akt(pAkt)和环磷酸腺苷(cAMP)反应元件结合蛋白(CREB)磷酸化的减少介导的。各种RCM均可增加肾小管细胞神经酰胺含量,其增加与细胞活力丧失密切相关。由RCM诱导的神经酰胺含量的升高和细胞损伤均被伏马菌素Bl逆转,但不被D 609逆转,表明神经酰胺从头合成的作用。与RCM一样,神经酰胺降低pAkt,降低Bcl-2表达,增强caspase-9和caspase-3活性,并导致细胞凋亡。在小鼠RCM肾病模型中也观察到伏马菌素B1的体内保护作用。此外,前列环素类似物贝前列素诱导内源性cAMP升高可有效预防放射造影剂肾病,其中涉及A激酶/PI 3-激酶/Akt激活和CREB磷酸化,这些发现表明神经酰胺合成抑制剂或贝前列素可能用于预防放射造影剂肾毒性。

项目成果

期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Involvement of de novo ceramide synthesis in radiocontrast-induced renal tubular cell injury
  • DOI:
    10.1038/sj.ki.5000057
  • 发表时间:
    2006-01-01
  • 期刊:
  • 影响因子:
    19.6
  • 作者:
    Itoh, Y;Yano, T;Oishi, R
  • 通讯作者:
    Oishi, R
A prostacyclin analog prevents radiocontrast nephropathy via phosphorylation of cyclic AMP response element binding protein
  • DOI:
    10.1016/s0002-9440(10)62352-8
  • 发表时间:
    2005-05-01
  • 期刊:
  • 影响因子:
    6
  • 作者:
    Yano, T;Itoh, Y;Oishi, R
  • 通讯作者:
    Oishi, R
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OISHI Ryozo其他文献

OISHI Ryozo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OISHI Ryozo', 18)}}的其他基金

The elucidation of the mechanisms underlying anticancer drug-induced peripheral neuropathy and its prophylaxis.
阐明抗癌药物引起的周围神经病变的机制及其预防。
  • 批准号:
    21590285
  • 财政年份:
    2009
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The elucidation of the mechanisms underlying antimicrobial agents-induced nephrotoxicity
阐明抗菌药物引起的肾毒性的机制
  • 批准号:
    19590252
  • 财政年份:
    2007
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Involvements of NO and histamine in radiographic contrast medium-induced pulmonary dysfunction
NO 和组胺参与放射造影剂诱发的肺功能障碍
  • 批准号:
    13672390
  • 财政年份:
    2001
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Save Kidneys in Cisplatin Chemotherapy by blocking HDAC6
顺铂化疗中通过阻断 HDAC6 拯救肾脏
  • 批准号:
    10841270
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
TIGIT in acute kidney injury and repair
TIGIT在急性肾损伤和修复中的作用
  • 批准号:
    10584173
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Cellular and Molecular Response to Gentamicin-Induced Injury in Underdeveloped Kidneys
发育不全的肾脏对庆大霉素引起的损伤的细胞和分子反应
  • 批准号:
    10591824
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
TWEAK-Fn14 regulation of non-canonical NF-kB signaling in chronic renal inflammation
TWEAK-Fn14 对慢性肾脏炎症中非经典 NF-kB 信号传导的调节
  • 批准号:
    10742538
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
REGULATORS OF CALCINEURIN PATHWAYS AS DIAGNOSTIC AND THERAPEUTIC TARGETS FOR NEPHROTIC SYNDROME
钙调磷酸酶途径的调节剂作为肾病综合征的诊断和治疗目标
  • 批准号:
    10560239
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
The role of RNase L in kidney function
RNase L 在肾功能中的作用
  • 批准号:
    10730414
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Mitigate cisplatin induced acute kidney injury through preservation of vasculature and proximal tubule
通过保护脉管系统和近端小管减轻顺铂引起的急性肾损伤
  • 批准号:
    10644372
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
Mitigate cisplatin induced acute kidney injury through preservation of vasculature and proximal tubule
通过保护脉管系统和近端小管减轻顺铂引起的急性肾损伤
  • 批准号:
    10661849
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
Mitigate cisplatin induced acute kidney injury through preservation of vasculature and proximal tubule
通过保护脉管系统和近端小管减轻顺铂引起的急性肾损伤
  • 批准号:
    10209816
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
Silk Fibers-Assisted 3D System for Large-Scale Culture of Human Urine-Derived Stem Cells Suitable for Late Mitotoxicity Testing
用于大规模培养人尿液干细胞的丝纤维辅助 3D 系统,适用于晚期有丝分裂毒性测试
  • 批准号:
    10417268
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了